At a glance
ClinicalIndex Comparison RecordN/ACompleted· 119 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Myocardial Injury and Quality of Life in Patients Recovered From the Pneumonia Associated With the Novel Coronavirus Infectious Disease COVID-19
Voronezh Regional Clinical Consultative and Diagnostic Center·observational·Posted Mar 11, 2021·Updated Nov 19, 2024
In Brief
An observational study for COVID-19 and 2 related conditions. Completed, enrolled 119 participants across 1 site.
Detailed Summary
In this observational study follow-up and dynamic observation will be conducted on the participants recovered from pneumonia caused by COVID-19. The main goal is an early diagnosis and detection of myocardial (heart) injury and quality of life in participants recovered from COVID-19 and follow-up in selected participants with present signs of myocarditis and/or myocardial fibrosis.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsCOVID-19, Myocardial Injury, Myocarditis Post Infection
CountriesRussia
Timeline
N/ACompletedFinished
202120222023202420252026
Enrollment StartSep 2020
First PostedMar 2021
Primary CompletionOct 2021
Study CompletionDec 2021
TodayJul 2026
First PostedMar 11, 2021
Enrollment StartSep 16, 2020
Primary CompletionOct 1, 2021
Study CompletionDec 31, 2021
TodayJul 2, 2026
Enrollment to primary: 1.0 yearsPosted 5.3 years ago